Exclusive interview for SPINOFF.COM with Avi Schroeder, the professor at Technion – Israel Institute of Technology, about the technology that enables tailoring the proper medicine to each cancer (lat. Carcinoma) patient before the treatment will begin. Together with his team, Professor Schroeder studies the interface of nanotechnology and medicine. They try to develop technologies that will improve the quality of life of patients, specifically of patients suffering from metastatic cancer. Their new technology prescreens many medicines inside the patient’s body before the treatment will actually begin. It’s somewhat like an allergy test, but it’s a cancer medicine test. It’s performed inside the patient’s body by screening many low doses of different medicines simultaneously inside the patient’s tumor.